Cargando…

Cutaneous adverse drug reactions in Indian population: A systematic review

BACKGROUND: Epidemiological data is limited for cutaneous adverse drug reactions (CADRs) in India. Most of the Indian studies have small sample size and are of limited duration. AIMS: The aim of this study is to analyze CADRs with reference to the causative drugs and their clinical characteristics i...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Tejas K, Thakkar, Sejal H, Sharma, DC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290186/
https://www.ncbi.nlm.nih.gov/pubmed/25593813
http://dx.doi.org/10.4103/2229-5178.146165
_version_ 1782352217623232512
author Patel, Tejas K
Thakkar, Sejal H
Sharma, DC
author_facet Patel, Tejas K
Thakkar, Sejal H
Sharma, DC
author_sort Patel, Tejas K
collection PubMed
description BACKGROUND: Epidemiological data is limited for cutaneous adverse drug reactions (CADRs) in India. Most of the Indian studies have small sample size and are of limited duration. AIMS: The aim of this study is to analyze CADRs with reference to the causative drugs and their clinical characteristics in Indian population. MATERIALS AND METHODS: As per selection criteria, electronic databases were searched for publications describing CADRs from January-1995 to April-2013 by two independent investigators. Data of the causative drugs and clinical characteristics were extracted and summarized by absolute numbers, percentages, ranges, and means as presented by the authors. The subgroup analysis of causative drugs was performed for causality assessment, severe or nonsevere reactions and occurrence of common CADRs. Studies showing “definite” and “probable” categories of causality analysis were labeled as “definite and probable causality (DPC) studies”. The other included studies were labeled as “non-DPC studies”. RESULTS: Of 8337 retrieved references, 18 prospective studies were selected for analysis. The pooled incidence was 9.22/1000 total among outpatient and inpatient cases. Commonly observed reactions were maculopapular rash (32.39%), fixed drug eruptions (FDEs) (20.13%), urticaria (17.49%) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) (6.84%). The major causative drug groups were antimicrobials (45.46%), nonsteroidal anti-inflammatory drugs (NSAIDs) (20.87%) and anti-epileptic drugs (14.57%). Commonly implicated drugs were sulfa (13.32%), β-lactams (8.96%) and carbamazepine (6.65%). High frequency of CADRs is observed with anti-epileptic drugs in DPC studies only. Carbamazepine, phenytoin and fluoroquinolones had higher severe to nonsevere cutaneous reaction ratio than other drugs. Antimicrobials were the main causative drugs for maculopapular rash, FDEs and SJS/TEN, and NSAIDs for the urticaria. The mortality for overall CADRs, SJS/TEN, and exfoliative dermatitis were 1.71%, 16.39%, and 3.57%, respectively. “Definitely preventable”, “probably preventable” and “not preventable” categories CADRs were 15.64%, 63.14%, and 34.64%, respectively. CONCLUSION: Antimicrobials, NSAIDs and antiepileptic are common causative agents of CADRs in India. Antiepileptic agents show high rates of severe cutaneous reactions.
format Online
Article
Text
id pubmed-4290186
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-42901862015-01-15 Cutaneous adverse drug reactions in Indian population: A systematic review Patel, Tejas K Thakkar, Sejal H Sharma, DC Indian Dermatol Online J Original Article BACKGROUND: Epidemiological data is limited for cutaneous adverse drug reactions (CADRs) in India. Most of the Indian studies have small sample size and are of limited duration. AIMS: The aim of this study is to analyze CADRs with reference to the causative drugs and their clinical characteristics in Indian population. MATERIALS AND METHODS: As per selection criteria, electronic databases were searched for publications describing CADRs from January-1995 to April-2013 by two independent investigators. Data of the causative drugs and clinical characteristics were extracted and summarized by absolute numbers, percentages, ranges, and means as presented by the authors. The subgroup analysis of causative drugs was performed for causality assessment, severe or nonsevere reactions and occurrence of common CADRs. Studies showing “definite” and “probable” categories of causality analysis were labeled as “definite and probable causality (DPC) studies”. The other included studies were labeled as “non-DPC studies”. RESULTS: Of 8337 retrieved references, 18 prospective studies were selected for analysis. The pooled incidence was 9.22/1000 total among outpatient and inpatient cases. Commonly observed reactions were maculopapular rash (32.39%), fixed drug eruptions (FDEs) (20.13%), urticaria (17.49%) and Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) (6.84%). The major causative drug groups were antimicrobials (45.46%), nonsteroidal anti-inflammatory drugs (NSAIDs) (20.87%) and anti-epileptic drugs (14.57%). Commonly implicated drugs were sulfa (13.32%), β-lactams (8.96%) and carbamazepine (6.65%). High frequency of CADRs is observed with anti-epileptic drugs in DPC studies only. Carbamazepine, phenytoin and fluoroquinolones had higher severe to nonsevere cutaneous reaction ratio than other drugs. Antimicrobials were the main causative drugs for maculopapular rash, FDEs and SJS/TEN, and NSAIDs for the urticaria. The mortality for overall CADRs, SJS/TEN, and exfoliative dermatitis were 1.71%, 16.39%, and 3.57%, respectively. “Definitely preventable”, “probably preventable” and “not preventable” categories CADRs were 15.64%, 63.14%, and 34.64%, respectively. CONCLUSION: Antimicrobials, NSAIDs and antiepileptic are common causative agents of CADRs in India. Antiepileptic agents show high rates of severe cutaneous reactions. Medknow Publications & Media Pvt Ltd 2014-12 /pmc/articles/PMC4290186/ /pubmed/25593813 http://dx.doi.org/10.4103/2229-5178.146165 Text en Copyright: © Indian Dermatology Online Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Patel, Tejas K
Thakkar, Sejal H
Sharma, DC
Cutaneous adverse drug reactions in Indian population: A systematic review
title Cutaneous adverse drug reactions in Indian population: A systematic review
title_full Cutaneous adverse drug reactions in Indian population: A systematic review
title_fullStr Cutaneous adverse drug reactions in Indian population: A systematic review
title_full_unstemmed Cutaneous adverse drug reactions in Indian population: A systematic review
title_short Cutaneous adverse drug reactions in Indian population: A systematic review
title_sort cutaneous adverse drug reactions in indian population: a systematic review
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4290186/
https://www.ncbi.nlm.nih.gov/pubmed/25593813
http://dx.doi.org/10.4103/2229-5178.146165
work_keys_str_mv AT pateltejask cutaneousadversedrugreactionsinindianpopulationasystematicreview
AT thakkarsejalh cutaneousadversedrugreactionsinindianpopulationasystematicreview
AT sharmadc cutaneousadversedrugreactionsinindianpopulationasystematicreview